This compensatory hypertrophy is pathologic because the process is maladaptive over time, with eventual myocyte loss, fibrosis, and ventricular dysfunction.
这种代偿性肥大随着时间的推移逐渐失去代偿，随着心肌细胞消失、纤维化，心室功能障碍。
OBJECTIVE: to evaluate the feasibility, safety and effectiveness of portal vein embolization (PVE) inducing compensatory hypertrophy of the remnant liver in clinical use.
目的：探讨门静脉栓塞(PVE)诱导肝叶代偿性增生临床应用的可行性、安全性、有效性。
Objective To evaluate the clinical feasibility, safety, and effectiveness of transcatheter portal vein embolization (PVE) inducing compensatory hypertrophy of the remnant liver.
目的探讨经导管门静脉栓塞（PVE）诱导肝叶代偿性增生临床应用的可行性、安全性、有效性。
Objective To evaluate the clinical feasibility, safety, and effectiveness of transcatheter portal vein embolization (PVE) inducing compensatory hypertrophy of the remnant liver.
目的探讨经导管门静脉栓塞（PVE）诱导肝叶代偿性增生临床应用的可行性、安全性、有效性。
应用推荐